Related Experiment Video
Updated: Jun 19, 2026

03:55
Production of Modified Autologous Conditioned Serum and Ex Vivo Assessment of Its Healing Potential in Murine Corneal Epithelium
Published on: March 24, 2023
THE SERUM TREATMENT OF WEIL'S DISEASE (SPIROCHAETOSIS ICTEROHAEMORRHAGICA).
The Journal of Experimental Medicine
|October 30, 2009
Summary
Therapeutic immune serum from immunized horses effectively eliminates Spirochaeta icterohaemorrhagiae from blood. This treatment also promotes antibody development and reduces spirochetes in organs, with minimal side effects.
Area of Science:
- Veterinary Immunology
- Bacteriology
Background:
- Spirochaeta icterohaemorrhagiae is a pathogenic bacterium.
- Effective treatments for infections caused by this spirochete are crucial in veterinary medicine.
Purpose of the Study:
- To evaluate the therapeutic properties of immune serum generated in horses against Spirochaeta icterohaemorrhagiae.
- To assess the impact of this serum on spirochete load in blood and organs, and on antibody development.
Main Methods:
- Horses were immunized with cultures of Spirochaeta icterohaemorrhagiae.
- The resulting immune serum was administered to assess its therapeutic effects.
- Spirochete counts in blood and organs, and antibody levels were monitored.
Main Results:
- The immune serum demonstrated significant efficacy in eliminating spirochetes from the circulating blood.
- Serum injections promoted the development of antibodies.
- A reduction in the number of spirochetes within organs was observed.
- Minor and transient secondary manifestations were noted.
Conclusions:
- Immune serum derived from immunized horses possesses potent therapeutic properties against Spirochaeta icterohaemorrhagiae.
- Further studies are required to ascertain the long-term effects on disease symptoms and overall prognosis.
Related Concept Videos
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Rocky Mountain Spotted Fever
Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.